[Severe subglottic hemangioma in the infant: corticotherapy, intubation or surgery?]

Rev Laryngol Otol Rhinol (Bord). 1991;112(5):449-51.
[Article in French]

Abstract

In the case of sub-glottic hemangioma, with serious immediate or cortico-resistant dyspnea, it is not always possible to wait for the growth of the laryngo-tracheal skeleton and the spontaneous involution of the angioma. On the basis of a series of 25 cases, we propose in these serious forms the following therapeutic escalation: very high dose corticotherapy, with betamethasone at 0.12 to 0.48 mg/kg/day for 15 days, followed by a degressive treatment over 6 weeks to 3 months; intubation to overcome a difficult stage in the event of aggravation of the angioma with a rhinopharyngitis. Embolization and the use of the laser proved unsatisfactory in the extensive forms of angiomas. In the event of failure of the preceding treatment, we perform a tracheotomy, the duration of which can be reduced by the surgical exeresis of the angioma with a widening of the larynx.

Publication types

  • English Abstract

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Embolization, Therapeutic
  • Female
  • Hemangioma / surgery
  • Hemangioma / therapy*
  • Humans
  • Infant
  • Intubation, Intratracheal
  • Laryngeal Neoplasms / surgery
  • Laryngeal Neoplasms / therapy*
  • Laryngostenosis / therapy
  • Laser Therapy
  • Male
  • Tracheotomy

Substances

  • Adrenal Cortex Hormones